TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Biologics in pregnancy – for the obstetrician

Key Statistics

  • 8–20 d — Adalimumab/infliximab half-life
  • 98–400% — Cord:maternal drug level (adalimumab/infliximab)
  • 16 wks — BSR: Stop infliximab by

Don't-miss facts

  1. Certolizumab = only anti-TNF safe throughout pregnancy (passive diffusion, no active Fc transport)

  2. BSR: stop infliximab by 16 weeks; stop etanercept/adalimumab in the third trimester

  3. No live vaccines (BCG, rotavirus) for 6 months if neonate exposed to anti-TNF beyond target stop gestation; all non-live vaccines safe

  4. Cord:maternal drug ratio can reach 98–400% for adalimumab/infliximab – active transfer maximal after 28 weeks

  5. FDA VACTERL signal (Carter et al.) is discredited: 1/41 cases met criteria, confounded by methotrexate; malformation rate = general population

  6. Active disease flare is more dangerous to mother/fetus than the biologic – placental insufficiency, FGR, pre-eclampsia, preterm birth

  7. Rituximab/belimumab: transient neonatal cytopenia + B-cell depletion up to 6 months; avoid conception for 12 months post-rituximab

  8. Breastfeeding is encouraged on all biologics; resume drug almost immediately postpartum (delay a few days if caesarean/perineal wound)

Discontinuation gestations (BSR)

Infliximab: stop by 16w Adalimumab: stop 3rd trimester (26–28w) Etanercept: stop 3rd trimester (30–32w)

Certolizumab: safe throughout

Abbreviation Key

  • TNF — tumour necrosis factor
  • IL — interleukin
  • BSR — British Society for Rheumatology
  • BCG — Bacillus Calmette–Guérin
  • FDA — US Food and Drug Administration
  • MMR — measles, mumps, rubella
  • VACTERL — vertebral, anal, cardiac, tracheo-oesophageal, renal,
  • TB — tuberculosis limb
  • CTLA-4 — cytotoxic T lymphocyte-associated antigen 4
  • Ig — immunoglobulin
  • SLE — systemic lupus erythematosus

Source: Soh MC, MacKillop L. Biologics in pregnancy – for the obstetrician. The Obstetrician & Gynaecologist 2016;18:25–32. doi:10.1111/tog.12250

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free